200 related articles for article (PubMed ID: 25323535)
1. LIF negatively regulates tumour-suppressor p53 through Stat3/ID1/MDM2 in colorectal cancers.
Yu H; Yue X; Zhao Y; Li X; Wu L; Zhang C; Liu Z; Lin K; Xu-Monette ZY; Young KH; Liu J; Shen Z; Feng Z; Hu W
Nat Commun; 2014 Oct; 5():5218. PubMed ID: 25323535
[TBL] [Abstract][Full Text] [Related]
2. MDM2-p53 mediate a miR-181c-3p/LIF axis to regulate low dose-rate radiation-induced DNA damage in human B lymphocytes.
Chen Y; Gong Y; Qin H; Wei S; Wei Y; Yu Y; Lin X; Shuai P; Wang T; Guo C; Wang Q; Li G; Meng L; Yi L
Ecotoxicol Environ Saf; 2024 Jan; 270():115848. PubMed ID: 38134636
[TBL] [Abstract][Full Text] [Related]
3. SRSF7 downregulation induces cellular senescence through generation of
Hong J; Min S; Yoon G; Lim SB
Aging (Albany NY); 2023 Dec; 15(24):14591-14606. PubMed ID: 38159247
[TBL] [Abstract][Full Text] [Related]
4. PHD1 regulates p53-mediated colorectal cancer chemoresistance.
Deschoemaeker S; Di Conza G; Lilla S; Martín-Pérez R; Mennerich D; Boon L; Hendrikx S; Maddocks OD; Marx C; Radhakrishnan P; Prenen H; Schneider M; Myllyharju J; Kietzmann T; Vousden KH; Zanivan S; Mazzone M
EMBO Mol Med; 2015 Oct; 7(10):1350-65. PubMed ID: 26290450
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer cells display chaperone dependency for the unconventional prefoldin URI1.
Lipinski KA; Britschgi C; Schrader K; Christinat Y; Frischknecht L; Krek W
Oncotarget; 2016 May; 7(20):29635-47. PubMed ID: 27105489
[TBL] [Abstract][Full Text] [Related]
6. ID1 and IGFBP3: roles in cellular senescence, cardiac development, angiogenesis and cancer diagnosis.
Shen C
J Transl Med; 2023 Nov; 21(1):797. PubMed ID: 37946234
[No Abstract] [Full Text] [Related]
7. LIF is a new p53 negative regulator.
Liu J; Yu H; Hu W
J Nat Sci; 2015; 1(7):e131. PubMed ID: 26161442
[TBL] [Abstract][Full Text] [Related]
8. HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells.
Wu L; Yu H; Zhao Y; Zhang C; Wang J; Yue X; Yang Q; Hu W
Oncotarget; 2015 Feb; 6(6):4406-17. PubMed ID: 25726527
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor (LIF).
Nicola NA; Babon JJ
Cytokine Growth Factor Rev; 2015 Oct; 26(5):533-44. PubMed ID: 26187859
[TBL] [Abstract][Full Text] [Related]
10. High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients.
Cheng YJ; Lee YC; Chiu WC; Tsai JW; Su YH; Hung AC; Chang PC; Huang CJ; Chai CY; Yuan SS
Oncotarget; 2014 Nov; 5(22):11564-75. PubMed ID: 25344919
[TBL] [Abstract][Full Text] [Related]
11. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
[TBL] [Abstract][Full Text] [Related]
12. ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1.
Wang Y; Bu F; Royer C; Serres S; Larkin JR; Soto MS; Sibson NR; Salter V; Fritzsche F; Turnquist C; Koch S; Zak J; Zhong S; Wu G; Liang A; Olofsen PA; Moch H; Hancock DC; Downward J; Goldin RD; Zhao J; Tong X; Guo Y; Lu X
Nat Cell Biol; 2014 Nov; 16(11):1092-104. PubMed ID: 25344754
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis.
Shin DH; Park JH; Lee JY; Won HY; Jang KS; Min KW; Jang SH; Woo JK; Oh SH; Kong G
Oncotarget; 2015 Jul; 6(19):17276-90. PubMed ID: 25938540
[TBL] [Abstract][Full Text] [Related]
14. Id1 Deficiency Protects against Tumor Formation in Apc(Min/+) Mice but Not in a Mouse Model of Colitis-Associated Colon Cancer.
Zhang N; Subbaramaiah K; Yantiss RK; Zhou XK; Chin Y; Benezra R; Dannenberg AJ
Cancer Prev Res (Phila); 2015 Apr; 8(4):303-11. PubMed ID: 25623217
[TBL] [Abstract][Full Text] [Related]
15. ERβ1 inhibits the migration and invasion of breast cancer cells through upregulation of E-cadherin in a Id1-dependent manner.
Zhou Y; Ming J; Xu Y; Zhang Y; Jiang J
Biochem Biophys Res Commun; 2015 Feb; 457(2):141-7. PubMed ID: 25514034
[TBL] [Abstract][Full Text] [Related]
16. LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker.
Bressy C; Lac S; Nigri J; Leca J; Roques J; Lavaut MN; Secq V; Guillaumond F; Bui TT; Pietrasz D; Granjeaud S; Bachet JB; Ouaissi M; Iovanna J; Vasseur S; Tomasini R
Cancer Res; 2018 Feb; 78(4):909-921. PubMed ID: 29269518
[TBL] [Abstract][Full Text] [Related]
17. Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer.
Wang MT; Fer N; Galeas J; Collisson EA; Kim SE; Sharib J; McCormick F
Nat Commun; 2019 Jul; 10(1):3055. PubMed ID: 31296870
[TBL] [Abstract][Full Text] [Related]
18. Cold-Inducible RNA Binding Protein Impedes Breast Tumor Growth in the PyMT Murine Model for Breast Cancer.
Lujan DA; Ochoa JL; Beswick EJ; Howard TA; Hathaway HJ; Perrone-Bizzozero NI; Hartley RS
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397942
[TBL] [Abstract][Full Text] [Related]
19. Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in mice.
Yang X; Wang J; Chang CY; Zhou F; Liu J; Xu H; Ibrahim M; Gomez M; Guo GL; Liu H; Zong WX; Wondisford FE; Su X; White E; Feng Z; Hu W
Nat Commun; 2024 Jan; 15(1):627. PubMed ID: 38245529
[TBL] [Abstract][Full Text] [Related]
20. LncRNA H19 Participates in Leukemia Inhibitory Factor Mediated Stemness Promotion in Colorectal Cancer Cells.
Zhu M; Yu R; Liu Y; Geng X; Liu Q; Liu S; Zhu Y; Li G; Guo Y; Xi X; Du B
Biochem Genet; 2024 Jan; ():. PubMed ID: 38198021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
